CATALIST-listed AOXIN Q&M reports lower revenue of RMB 140m for full year ended 31 December 2022
– Revenue from primary healthcare business remained resilient with a drop of 7.3% despite massive lock-downs in China in 2022
Read More– Revenue from primary healthcare business remained resilient with a drop of 7.3% despite massive lock-downs in China in 2022
Read More